Wockhardt shares rise 10% after Zaynich aids successful liver transplant trial
Wockhardt's shares surged 8.6% after its antibiotic Zaynich successfully treated a US cancer patient, enabling a liver transplant and chemotherapy. The drug is nearing Phase III trials for global approval.
Site référencé: The Economic Times
The Economic Times
Vishal Mega Mart shares surge 8% after Q1 profit jumps 37% YoY
14/08/2025
Muthoot Finance shares hit 10% upper circuit on posting 65% YoY growth in Q1 profit
14/08/2025
Jubilant Foodworks shares rally 5% after Q1 PAT grows 60% YoY, but brokerages trim targets. Here’s why
14/08/2025
Technology to drive consolidation in broking and asset management : Saurabh Mukherjea
14/08/2025
Sebi permits use of mutual funds for IAs, RAs deposit compliance
13/08/2025
IRCTC Q1 Results : PAT rises 8% YoY to Rs 331 crore
13/08/2025
